Avacta Marks Pivotal Moment: First Patient Dosed in AVA6103 Cancer Trial
Tiny Swimmers, Big Hope: Sperm-Powered Microrobots Revolutionize Cancer Drug Delivery
The Future is Here: Scientists Engineer 'Sperm-Bots' for Revolutionary Targeted Drug Delivery